Abstract
A 72-year-old patient with multiple myeloma was admitted to the intensive care unit because of hypercalcemic crisis and acute renal failure. After 7 days of comprehensive therapy including diuretics, steroids, calcitonin, and intermittent hemodialysis (IHD) with low-calcium dialysate, calcium still reached high levels between IHD treatments and thrombocytopenia developed after chemotherapy. CWHDF with calcium-free bicarbonate dialysate was started. Anticoagulation with 2.2 % citrate was performed in order to chelate calcium, and thus treat the hypercalcemia, and to provide regional anticoagulation, and thus reduce the risk of bleeding due to thrombocytopenia. CWHDF with citrate anticoagulation was continued for 6 days, and standard heparin anticoagulation was started when the hypercalcemia and thrombocytopenia abated.
References
Barlogie B, Jagannath S, Epstein J, Munshi N, Siegel D, Desikan KR, Feinman R, Hsu PL, von Bremen K, Tricot G (1997) Biology and therapy of multiple myeloma in 1996. Semin Hematol 34 [Suppl 1]: 67–72
Watters J, Gerrard G, Dodwell D (1996) The management of malignant hypercalcemia. Drugs 52: 837–848
Uchida M, Kamata K, Okubo M (1995) Renal dysfunction in multiple myeloma. Intern Med 34: 364–370
Camus C, Charasse C, Jouannic-Montier I, Seguin P, Tulzo YL, Bouget J, Thomas R (1996) Calcium free hemodialysis: experience in the treatment of 33 patients with severe hypercalcemia. Intensive Care Med 22:116–121
Forni LG, Hilton PJ (1997) Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med 336: 1303–1309
Mehta RL, McDonald BP, Ward DM (1991) Regional citrate anticoagulation for continuous arteriovenous hemodialysis. In: Sieberth HG, Mann H, Stummvoll HK (eds) Continuous hemofiltration. Contrib Nephrol 93: 210–214
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Šrámek, V., Novák, I., Matějovič, M. et al. Continuous venovenous hemodiafiltration (CWHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia. Intensive Care Med 24, 262–264 (1998). https://doi.org/10.1007/s001340050562
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001340050562